Healthtech Startups

Gasgon Medical develops fluid management devices for the clinical market, including AirVault, a single-use device that removes air bubbles from IV fluids. The company builds tools to improve IV infusion for patients and clinicians in healthcare settings.

1 investor

Gastfreund offers a modular guest experience platform with a guest app, information channel, and team communication tools (Hotelboard) for hotels, resorts, campsites and vacation rentals as well as healthcare and care facilities such as hospitals, rehab and senior residences. The platform centralizes stay-related information, automates recurring tasks, and supports guest and staff communication with auto-translation.

1 investor

Gastrocare Partners operates a network of gastrointestinal practices in the western United States, bringing together established clinical practices to enable collaborative care and advanced interventional endoscopic treatments.

1 investor

Gastro Health is a medical group of board-certified physicians and advanced practitioners specializing in gastrointestinal disorders, nutrition, and digestive health. The group provides comprehensive care including evaluation, treatment, surgery, colorectal procedures, infusion services, diagnostic studies, nutrition therapy, and weight loss programs.

1 investor

Gastroenterology Consultants of San Antonio is a gastroenterology medical practice serving patients in South Texas. Its GI physicians provide diagnosis and treatment for digestive and gastrointestinal conditions.

1 investor

The Bill & Melinda Gates Foundation is a philanthropic organization that funds research, programs, and initiatives addressing global health, development, and education challenges, particularly affecting low-income populations in developing countries.

1 investor

Gather Group builds a platform that coordinates personal care teams—family, friends, and caregivers—to support patients through care transitions and help them enact their recovery plans. The platform targets hospitals, GPs, and rehabilitation facilities seeking to improve patient outcomes by shifting care coordination from individual self-management to a team-based approach.

1 investor

GattaCo develops a blood plasma separator device that enables point-of-care collection and transport of lab-quality plasma for remote blood testing and monitoring. The A-PON Plasma Separator uses passive elution technology to extract plasma from finger-stick blood samples for later laboratory analysis.

1 investor

Gavi is a public-private partnership that funds vaccination programs in developing countries through contributions from governments, foundations, corporations, and private donors. The organization mobilizes resources to provide vaccine access and shape vaccine markets in supported nations.

1 investor

Seattle's LGBTQ+ Center is a community organization providing health services, wellness programs, arts initiatives, and resource navigation for LGBTQ individuals in the Seattle area. The center operates as a hub offering HIV/STI testing, PrEP navigation, healthcare support, youth programs, and cultural programming.

1 investor

GBI Biomanufacturing manufactures stem cells for regenerative medicine applications, including treatments for orthopedic injuries, wound care, and arthritic conditions. The company operates a 40,000-square-foot facility in Plantation, Florida and has expanded its stem-cell production capacity to serve growing demand driven by new state legislation permitting broader clinical use of stem-cell therapies.

1 investor

CcHUB Growth Capital is an early-stage venture fund investing between ₦10 million and ₦30 million in seed and early-stage for-profit technology startups building solutions to local challenges in Nigeria. It provides funding, business advisory, and network connections to help portfolio companies scale and attract follow-on funding.

1 investor

GREEN VET provides diagnostic testing, health screening, and management services for companion animals, serving veterinarians and pet owners in South Korea. The company operates as a specialized animal healthcare provider offering laboratory diagnostics, digital pathology, and preventive care services.

1 investor

A South Korean developer of biopharmaceutical products for veterinary use, focused on animal health and welfare through innovative drug development and biopharmaceutical research.

1 investor

Gearbox Biosciences develops Pop-Out-Plasmid (POP) technology, an E. coli platform that produces plasmid DNA and recombinant proteins without antibiotic selection markers or chemical inducers like IPTG, while decoupling growth from production. Its products serve biopharma partners in gene therapy, cell therapy, and vaccine manufacturing, and the technology is available for licensing.

1 investor

GeBBS provides revenue cycle management and business process outsourcing services to healthcare organizations, with emphasis on HIPAA compliance, data security, and business continuity planning.

1 investor

Gedea Biotech develops pHyph, an antibiotic-free treatment for bacterial vaginosis and other common vaginal infections aimed at supporting a healthy microbiome. A spin-out from Lund University, the company focuses on women's health and is pursuing partnerships and regulatory approvals in Europe and the US.

1 investor

Gelesis develops an oral superabsorbent hydrogel platform (OHS) built from naturally derived materials that works locally in the GI tract to influence satiety signals and support metabolic health. Its product Plenity is a clinically studied aid for weight management in overweight or obese adults with a BMI of 25 to 40 when combined with diet and exercise.

1 investor

GENinCode provides genomic testing for cardiovascular disease prevention and diagnosis using monogenic and polygenic risk assessment to identify patient risk and enable targeted preventive treatment. The company also offers testing for ovarian cancer surveillance, leveraging its proprietary software platform to combine genetic profiles with clinical risk factors.

1 investor

GEn1E is a life sciences company developing next-generation substrate-specific p38α kinase inhibitors to treat rare and inflammatory diseases. It combines a curated database linking genes, pathways, proteins, diseases, and compounds with machine learning models spanning drug discovery through clinical trials.

1 investor

GenBody manufactures rapid diagnostic test kits, fluorescence immunoassay kits, and analysis equipment for human and veterinary use, including tests for infectious diseases, drug screening, and chronic conditions. The company also produces laboratory animals for research purposes.

1 investor

GenDx develops molecular diagnostic reagents, software, and services for transplant patient outcomes. Operating globally since 2005, the company serves the healthcare and diagnostics industry with specialized tools for transplant diagnostics.

1 investor

Gene BioSystems manufactures ready-to-use qPCR reagent kits for quantitative PCR analysis across major real-time PCR systems. The products are designed for research laboratories and diagnostic facilities requiring molecular biology testing reagents.

1 investor

GeneDx provides advanced genetic testing and clinical interpretation services to help clinicians diagnose rare and inherited genetic disorders, with AI-driven genomic intelligence that supports patient care decisions and accelerates research and drug discovery.

1 investor